{ "model": { "rank": 3548, "code": "thing-q87719492", "model_id": "vr.tr.covid-19-vaccine", "name": "COVID-19 vaccine", "purpose": "Enable an AI agent to identify a COVID-19 vaccine, assess its documented suitability and physical usability, and determine which handling or use decisions require current product-specific evidence and authority.", "family": "Thing Registry", "category": "Physical world and living systems", "status": "research-draft", "kind": "thing", "plane": "PHY", "domain": "PHY.OBJ", "industry": "", "version": "", "url": "/models/thing/q87719492/", "tier": 2, "score": 84, "payload": { "layer": "wikidata", "aliases": [ "bacTRL-Spike", "Walvax COVID-19 vaccine", "mRNA-1273 vaccine", "zorecimeran", "Pfizer–BioNTech COVID-19 vaccine", "BriLife", "NDV-HXP-S", "DelNS1-2019-nCoV-RBD-OPT", "VBI-2902", "Mambisa", "Sanofi/GSK SARS-CoV-2 subunit vaccine", "UB-612", "RBD SARS-CoV-2 HBsAg VLP", "hAd5-S-Fusion+N-ETSD", "VXA-CoV2-1", "MVC COVID-19 Vaccine", "ARCT-154", "AZD1222", "Ad5-nCoV", "BBIBP-CorV", "NVX-CoV2373", "Anhui Zhifei Longcom Biopharmaceutical COVID-19 vaccine candidate", "COVAX-19", "Gam-COVID-Vac", "Ad26.COV2.S", "EpiVacCorona", "AdimrSC-2f", "Valneva COVID-19 vaccine", "COVIran Barekat", "WIBP-CorV", "Chinese Academy of Medical Sciences COVID-19 vaccine", "Minhai COVID-19 vaccine", "CoronaVac", "Covaxin / BBV152", "SOBERANA 02", "Corbevax", "Zhongyianke Biotech–Liaoning Maokangyuan Biotech COVID-19 vaccine", "SCTV01C", "QazCovid-in", "CoviVac" ], "aliasCount": 58, "merged": 58, "knownIn": 84, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q87719492", "url": "https://www.wikidata.org/wiki/Q87719492", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-07T14:31:54Z", "providers": [ "Codex" ], "breadth": "recalled by Codex without web access - no source was read", "missingProviders": [], "pass": 2, "cost": { "grok": { "seconds": 28.1, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.3\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a07c47-2d9c-7492-9ada-8821602b47ce\n--------\nuser\nDescribe what is already known about one registered thing. Answer as JSON only, no prose around it.\n\nThing: COVID-19 vaccine\nSense to describe: (none recorded)\nDomain code: PHY.OBJ\nAlso known as: (none)\n\n\nContext for this batch of 1001 things:\n# Batch 004: 100", "usd": 0, "recall": true }, "codex": { "seconds": 80.4, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.3\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a07c47-2d8a-7c40-bce1-75bf99cd7306\n--------\nuser\nYou are drafting a Vercy meta-model for one registered thing. Answer as JSON only, no prose around it.\n\nThing: COVID-19 vaccine\nRegistry id: vr.tr.covid-19-vaccine\nPlane / domain: PHY / PHY.OBJ\nRegistry definition: (none recorded)\nNames folded into this entry:" } } }, "metaModel": { "id": "THING-Q87719492", "registryId": "vr.tr.covid-19-vaccine", "name": "COVID-19 vaccine", "version": "0.1.0-research.1", "entryKind": "thing", "family": "Thing Registry", "domain": [ "PHY.OBJ" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q87719492/", "model": { "registry_id": "vr.tr.covid-19-vaccine", "name": "COVID-19 vaccine", "purpose": "Enable an AI agent to identify a COVID-19 vaccine, assess its documented suitability and physical usability, and determine which handling or use decisions require current product-specific evidence and authority.", "definition": "A COVID-19 vaccine is a biological preparation designed to induce immune protection against disease caused by SARS-CoV-2, particularly severe illness, by presenting viral antigens or instructions for producing them.", "scope_statement": "This model owns COVID-19 vaccine as a kind of physical biological preparation intended to induce active immunity against SARS-CoV-2 to prevent COVID-19, with linked distinctions among products, formulations, presentations, lots and individual doses.", "in_scope": [ "Vaccine platform, antigen composition and intended immune target", "Product, formulation, presentation, lot and dose identity", "Manufacturing quality, lot release and documented integrity", "Storage, transport, preparation and usable-dose conditions", "Product-specific evidence, safety information and authorized conditions of use" ], "out_of_scope": [ "SARS-CoV-2 biology, variant classification and COVID-19 disease models", "Individual patient records, diagnoses and vaccination histories", "Vaccination encounters and administration procedures as clinical activities", "Population vaccination programmes, procurement systems and allocation policies", "Standalone delivery devices and general cold-chain infrastructure", "Other vaccines, passive antibody products and antiviral medicines" ], "distinguishing_features": [ "The preparation is intended to elicit active immunity against SARS-CoV-2; direct antiviral action or delivery of preformed antibodies does not establish membership.", "Its intended indication includes prevention of COVID-19; being a vaccine against another infection is insufficient.", "An antigen sequence, research reagent or platform description alone is not a COVID-19 vaccine preparation.", "Investigational status and marketing authorization are separate from identity: a candidate preparation can belong to this kind without being authorized for routine use.", "A named vaccine product, a composition update, a lot and an individual dose are distinct levels of identity within this kind." ], "characteristics": [ { "name": "Vaccine platform", "kind": "category", "unit_or_values": "Documented platform, such as mRNA, viral vector, protein subunit or inactivated virus; other or unknown", "why_it_matters": "Distinguishes how the preparation supplies or expresses its immune target and which product-specific constraints need investigation." }, { "name": "Antigen composition", "kind": "relation", "unit_or_values": "References to documented antigen components, target sequences or strains, and composition version", "why_it_matters": "Separates formulations that share a product family name but differ in intended immune targets." }, { "name": "Presentation", "kind": "category", "unit_or_values": "Product-documented container, dosage form, concentration and nominal dose count", "why_it_matters": "Determines how the physical supply is recognized and prepared." }, { "name": "Dose specification", "kind": "measurement", "unit_or_values": "Volume in mL and active-component quantity in the units specified for the formulation", "why_it_matters": "Prevents confusion among formulation concentration, container content and administered dose." }, { "name": "Product and lot traceability", "kind": "relation", "unit_or_values": "Manufacturer, product identifier, formulation identifier, lot number and supporting records", "why_it_matters": "Connects a physical supply to release documentation, expiry information and applicable notices." }, { "name": "Storage and excursion history", "kind": "relation", "unit_or_values": "Temperature records in °C, durations with time units, handling events and product-specific excursion assessments", "why_it_matters": "Supports an evidence-based assessment of whether recorded handling permits further use." }, { "name": "Preparation state", "kind": "state", "unit_or_values": "Product-applicable states such as unopened, thawed, diluted, punctured, prepared or discarded", "why_it_matters": "Identifies which handling rules and remaining-use limits apply." }, { "name": "Applicable use-by limit", "kind": "measurement", "unit_or_values": "Date and time with time zone, linked to expiry and any shorter handling-dependent limit", "why_it_matters": "Makes the basis and timing of physical usability explicit." }, { "name": "Regulatory status", "kind": "state", "unit_or_values": "Jurisdiction- and date-specific status with authority and documentary reference", "why_it_matters": "Prevents an authorization in one setting or period from being treated as universal." }, { "name": "Evidence-supported use", "kind": "relation", "unit_or_values": "Links to population, regimen, comparator, outcome, follow-up period and safety evidence", "why_it_matters": "Keeps claims about benefit and risk attached to the conditions actually studied." } ], "affordances": [ "Identify a physical supply against product, formulation, presentation and lot documentation.", "Compare antigen compositions and presentations without assuming products are interchangeable.", "Assess recorded storage and preparation history against the applicable product instructions.", "Flag a supply for quarantine or expert review when identity, integrity or usable-dose status is unresolved.", "Retrieve current jurisdiction-specific conditions of use and supporting evidence.", "Trace a lot to quality notices, recalls or safety investigations." ] }, "sources": [], "structure": { "bundles": [ { "id": "vaccine-identity-and-composition", "name": "Vaccine identity and composition", "description": "Establishes which COVID-19 vaccine preparation is represented and how its immune-targeting composition is distinguished.", "rationale": "A shared COVID-19 indication or product family name does not uniquely identify a formulation.", "layers": [ { "id": "platform-and-immune-target", "name": "Platform and immune target", "description": "Describes the preparation's platform and intended antigenic target.", "findings": [ { "id": "active-immunization-identity", "name": "Active immunization identity", "description": "Record the documented basis for classifying the preparation as a COVID-19 vaccine and its platform.", "questions": [ { "text": "What preparation and platform are intended to induce active immunity against SARS-CoV-2?", "kind": "definition", "id": "active-immunization-identity-q01" }, { "text": "What distinguishes this preparation from an antigen reagent, passive antibody product or antiviral medicine?", "kind": "boundary", "id": "active-immunization-identity-q02" } ] } ] }, { "id": "composition-and-formulation-version", "name": "Composition and formulation version", "description": "Separates antigen updates and formulation differences within a vaccine product family.", "findings": [ { "id": "documented-composition", "name": "Documented composition", "description": "Record antigen components, relevant excipients and the version of the formulation being represented.", "questions": [ { "text": "Which antigen components and target sequences or strains define this composition?", "kind": "definition", "id": "documented-composition-q01" }, { "text": "Which manufacturer or regulatory document identifies this formulation and distinguishes it from earlier or parallel versions?", "kind": "provenance", "id": "documented-composition-q02" } ] } ] } ] }, { "id": "presentation-and-lot-assurance", "name": "Presentation and lot assurance", "description": "Connects the vaccine's physical presentation to dose specifications, manufacturing identity and lot disposition.", "rationale": "Formulation mix-ups and lot-specific quality issues cannot be resolved using the generic vaccine name.", "layers": [ { "id": "container-and-dose-specification", "name": "Container and dose specification", "description": "Identifies the container contents and the documented relationship between concentration, preparation and dose.", "findings": [ { "id": "presentation-specific-dose", "name": "Presentation-specific dose", "description": "Record presentation identifiers and dose quantities without generalizing across formulations.", "questions": [ { "text": "What dosage form, container, concentration and nominal dose count identify this presentation?", "kind": "definition", "id": "presentation-specific-dose-q01" }, { "text": "What volume and active-component quantity define a dose for each documented use of this formulation?", "kind": "measurement", "id": "presentation-specific-dose-q02" } ] } ] }, { "id": "lot-traceability-and-release", "name": "Lot traceability and release", "description": "Links a vaccine lot to its origin, release evidence and subsequent quality disposition.", "findings": [ { "id": "lot-quality-disposition", "name": "Lot quality disposition", "description": "Record evidence of lot identity and whether its documented quality status permits distribution or use.", "questions": [ { "text": "Which records connect this lot to the manufacturer, formulation, expiry assignment and applicable release decision?", "kind": "provenance", "id": "lot-quality-disposition-q01" }, { "text": "Does a quality notice, suspected falsification, recall or unresolved release status require this lot to be held for review?", "kind": "action", "id": "lot-quality-disposition-q02" } ] } ] } ] }, { "id": "cold-chain-and-dose-usability", "name": "Cold chain and dose usability", "description": "Represents the handling history and state transitions that determine whether a physical vaccine supply remains usable.", "rationale": "Printed expiry alone cannot establish usability after storage changes or preparation.", "layers": [ { "id": "storage-and-excursion-assessment", "name": "Storage and excursion assessment", "description": "Relates observed transport and storage conditions to the exact presentation's documented limits.", "findings": [ { "id": "temperature-history-assessment", "name": "Temperature history assessment", "description": "Record temperature evidence, gaps and any authorized assessment of excursions.", "questions": [ { "text": "What temperature ranges and durations were recorded during transport and storage, and where are records missing?", "kind": "measurement", "id": "temperature-history-assessment-q01" }, { "text": "Which product-specific instructions or documented expert assessment determine the disposition of any excursion?", "kind": "action", "id": "temperature-history-assessment-q02" } ] } ] }, { "id": "preparation-and-use-by-state", "name": "Preparation and use-by state", "description": "Tracks applicable preparation events and the time limits they trigger.", "findings": [ { "id": "remaining-usability", "name": "Remaining usability", "description": "Determine the applicable use-by limit from documented preparation history and product instructions.", "questions": [ { "text": "Which applicable thawing, dilution, puncture or preparation events occurred, at what times and under what conditions?", "kind": "measurement", "id": "remaining-usability-q01" }, { "text": "Given those events, expiry information and observed integrity, may the supply remain available or must it be held or discarded?", "kind": "action", "id": "remaining-usability-q02" } ] } ] } ] }, { "id": "protection-and-safety-evidence", "name": "Protection and safety evidence", "description": "Organizes evidence about immune responses, clinical protection and adverse outcomes without detaching claims from their study conditions.", "rationale": "COVID-19 vaccine evidence depends on composition, circulating variants, population, regimen and elapsed time.", "layers": [ { "id": "immune-response-and-clinical-outcomes", "name": "Immune response and clinical outcomes", "description": "Distinguishes laboratory immune measurements from evidence about clinical outcomes.", "findings": [ { "id": "bounded-protection-claims", "name": "Bounded protection claims", "description": "Record each protection claim with its endpoint, study context and uncertainty.", "questions": [ { "text": "Does the evidence measure an immune response, infection, symptomatic disease, hospitalization or another specified outcome?", "kind": "definition", "id": "bounded-protection-claims-q01" }, { "text": "What estimate and uncertainty apply to which formulation, population, regimen, variant context and follow-up interval?", "kind": "measurement", "id": "bounded-protection-claims-q02" } ] } ] }, { "id": "adverse-outcomes-and-signal-assessment", "name": "Adverse outcomes and signal assessment", "description": "Separates observed events after vaccination from assessed adverse reactions and unresolved signals.", "findings": [ { "id": "qualified-safety-evidence", "name": "Qualified safety evidence", "description": "Record safety findings with the population, exposure denominator, observation window and assessment status.", "questions": [ { "text": "Which study or surveillance assessment supports each safety concern, and how does it address causality?", "kind": "provenance", "id": "qualified-safety-evidence-q01" }, { "text": "What frequency or comparative risk is reported for which formulation, dose sequence, population and observation window?", "kind": "measurement", "id": "qualified-safety-evidence-q02" } ] } ] } ] }, { "id": "authorized-use-and-decision-boundaries", "name": "Authorized use and decision boundaries", "description": "Connects the vaccine to dated regulatory conditions, recommendations and limits on automated interpretation.", "rationale": "Physical usability, regulatory authorization and suitability for a particular recipient require distinct evidence.", "layers": [ { "id": "jurisdiction-and-product-status", "name": "Jurisdiction and product status", "description": "Identifies the exact formulation's regulatory position in a specified place and period.", "findings": [ { "id": "dated-regulatory-basis", "name": "Dated regulatory basis", "description": "Record the responsible authority, operative decision and conditions attached to the product.", "questions": [ { "text": "Which authority and dated document establish this formulation's status in the relevant jurisdiction?", "kind": "provenance", "id": "dated-regulatory-basis-q01" }, { "text": "What populations, indications and conditions are covered, and what uses fall outside that document?", "kind": "boundary", "id": "dated-regulatory-basis-q02" } ] } ] }, { "id": "regimen-and-recipient-interface", "name": "Regimen and recipient interface", "description": "Links product-specific use conditions to external clinical assessment without owning a patient's care plan.", "findings": [ { "id": "use-conditions-and-review", "name": "Use conditions and review", "description": "Record applicable regimen guidance, contraindications and precautions with their sources and effective dates.", "questions": [ { "text": "Which current documents specify dose intervals, prior-vaccination handling, interchangeability, contraindications and precautions for this formulation?", "kind": "provenance", "id": "use-conditions-and-review-q01" }, { "text": "Which missing recipient details or conflicting instructions require clinical review before a use decision can be made?", "kind": "action", "id": "use-conditions-and-review-q02" } ] } ] } ] }, { "id": "evidence-and-external-alignment", "name": "Evidence and external alignment", "description": "What the world already says about this thing, gathered so the model can be checked against it.", "rationale": "A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.", "layers": [ { "id": "reported-evidence", "name": "Reported evidence", "description": "Findings from the breadth pass, kept separate from the structural claims.", "findings": [ { "id": "evidence-confidence-notes", "name": "Check these first", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "This is recalled knowledge, not source-verified research.", "Current formulations, authorizations and vaccination recommendations require jurisdiction-specific verification.", "Dose volumes, storage conditions and adverse-event frequencies must be checked against the exact product and age-specific formulation." ], "questions": [ { "id": "evidence-confidence-notes-q01", "text": "Which of these check these first hold for the sense of COVID-19 vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-kinds", "name": "Kinds and varieties", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Messenger RNA vaccines", "Non-replicating viral vector vaccines", "Protein subunit vaccines", "Inactivated whole-virus vaccines", "DNA vaccines", "Virus-like particle vaccines" ], "questions": [ { "id": "evidence-kinds-q01", "text": "Which of these kinds and varieties hold for the sense of COVID-19 vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-identifiers", "name": "Identifiers and schemes", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "scheme": "WHO Anatomical Therapeutic Chemical classification", "value_or_pattern": "J07BN", "note": "Group for COVID-19 vaccines; individual vaccine categories have more specific codes." }, { "scheme": "Manufacturer lot or batch number", "value_or_pattern": "Manufacturer-assigned alphanumeric identifier", "note": "Identifies a production batch for traceability and recalls, rather than the vaccine class." } ], "questions": [ { "id": "evidence-identifiers-q01", "text": "Which of these identifiers and schemes hold for the sense of COVID-19 vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-standards-and-regulation", "name": "Standards and regulation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "WHO Technical Report Series 1004, Annex 9: Good manufacturing practices for biological products.", "United States FDA: biological product licensing requirements under 21 CFR Part 601.", "European Commission: EudraLex Volume 4, Annex 2, governing manufacture of biological active substances and medicinal products." ], "questions": [ { "id": "evidence-standards-and-regulation-q01", "text": "Which of these standards and regulation hold for the sense of COVID-19 vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-real-world-use", "name": "Real-world use", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Active immunization to reduce COVID-19 illness, hospitalization and death.", "Initial vaccination courses and subsequent doses under applicable public health recommendations.", "Use of updated antigen formulations to improve protection against circulating viral variants.", "Vaccination programmes prioritizing populations at increased risk of severe disease." ], "questions": [ { "id": "evidence-real-world-use-q01", "text": "Which of these real-world use hold for the sense of COVID-19 vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-measurements", "name": "Typical measurements", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "quantity": "Volume administered per intramuscular injection", "typical_range": "Common presentations use 0.2-0.5; the exact volume depends on product, formulation and age group", "unit": "mL" } ], "questions": [ { "id": "evidence-measurements-q01", "text": "Which of these typical measurements hold for the sense of COVID-19 vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-failure-modes-and-hazards", "name": "Failure modes and hazards", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Breakthrough infection can occur because protection against infection is incomplete, wanes over time and varies with viral evolution.", "Storage excursions, incorrect dilution or use beyond an allowed storage interval can compromise product quality.", "Administration errors can involve the wrong formulation, dose volume, route or schedule.", "Transient injection-site pain, fatigue, headache and fever can occur; severe allergic reactions are rare.", "Rare adverse events vary by platform and product, including myocarditis or pericarditis after mRNA vaccination and thrombosis with thrombocytopenia after certain adenoviral vector vaccines." ], "questions": [ { "id": "evidence-failure-modes-and-hazards-q01", "text": "Which of these failure modes and hazards hold for the sense of COVID-19 vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-regional-variation", "name": "Regional variation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Authorized products, eligible age groups and recommended schedules differ by jurisdiction.", "Available vaccine platforms and formulations differ with procurement, manufacturing capacity and storage infrastructure.", "National regulators determine authorization; WHO emergency use listing is a separate assessment." ], "questions": [ { "id": "evidence-regional-variation-q01", "text": "Which of these regional variation hold for the sense of COVID-19 vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-neighbours", "name": "Neighbouring kinds and how to tell them apart", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "name": "Vaccine", "difference": "The broader class targets many pathogens or diseases; this subclass specifically targets SARS-CoV-2 to prevent COVID-19." }, { "name": "COVID-19 antiviral medicine", "difference": "An antiviral directly inhibits viral processes; a vaccine induces an immune response." }, { "name": "SARS-CoV-2 monoclonal antibody product", "difference": "An antibody product supplies passive immunity; a vaccine stimulates active immunity." }, { "name": "COVID-19 vaccine product", "difference": "A named product has a particular manufacturer, composition and authorization; this entry covers the vaccine class." } ], "questions": [ { "id": "evidence-neighbours-q01", "text": "Which of these neighbouring kinds and how to tell them apart hold for the sense of COVID-19 vaccine this model covers, and on what evidence?", "kind": "provenance" } ] } ] } ] } ] }, "openQuestions": [ "Does an existing Vercy vaccine or COVID-19 vaccine world model already own this concept, requiring a registry link instead of a separate publication?", "Which authoritative product documents should anchor the initial coverage of platforms, antigen compositions and presentation variants?", "How should composition updates and age-specific formulations be identified consistently when product naming differs across jurisdictions?", "Which current sources establish formulation-specific storage limits, excursion disposition rules and preparation-dependent use-by limits?", "Where does evidence remain insufficient to transfer protection, safety or interchangeability conclusions between formulations, populations or variant contexts?" ], "statistics": { "bundles": 6, "layers": 11, "findings": 19, "questions": 29 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "unclassified", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a COVID-19 vaccine, record what state it is in, and decide what may be done with it.", "whatItIs": "Enable an AI agent to identify a COVID-19 vaccine, assess its documented suitability and physical usability, and determine which handling or use decisions require current product-specific evidence and authority.", "characteristics": { "substance": "material", "origin": "manufactured", "agency": "inert", "mobility": "varies" }, "whatYouCanDoWithIt": [ "observed and measured" ], "distinguishingFeatures": [ "Names folded into this entry, which a task may need to split apart again: bacTRL-Spike, Walvax COVID-19 vaccine, mRNA-1273 vaccine, zorecimeran, Pfizer–BioNTech COVID-19 vaccine, BriLife, NDV-HXP-S, DelNS1-2019-nCoV-RBD-OPT, VBI-2902, Mambisa, Sanofi/GSK SARS-CoV-2 subunit vaccine, UB-612.", "58 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.", "Described in 84 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a COVID-19 vaccine, and on what evidence are they told apart?" ], "whatItIsMadeOf": "matter you can touch", "physicalCharacter": [ "Mobility varies between examples.", "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "observe it, measure it, record its state" ], "howItIsRecognised": [ "Recognised by form and material. The registry holds no appearance data, so what a COVID-19 vaccine looks like has to come from research." ], "relatedModels": [ { "relation": "covers", "note": "Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.", "targets": [ "bacTRL-Spike", "Walvax COVID-19 vaccine", "mRNA-1273 vaccine", "zorecimeran", "Pfizer–BioNTech COVID-19 vaccine", "BriLife", "NDV-HXP-S", "DelNS1-2019-nCoV-RBD-OPT", "VBI-2902", "Mambisa", "Sanofi/GSK SARS-CoV-2 subunit vaccine", "UB-612" ] } ], "standing": "Described in 84 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 58 finer distinctions are held inside this entry as names rather than as separate models.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one COVID-19 vaccine from another, and a COVID-19 vaccine from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a COVID-19 vaccine sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a COVID-19 vaccine from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "form-and-composition", "name": "Form, composition and condition", "description": "What a COVID-19 vaccine is made of, what shape and size it takes, and what state it is in.", "rationale": "A physical thing can be measured, and a model that cannot record its measurements cannot support any decision that depends on them.", "layers": [ { "id": "form-and-dimensions", "name": "Form and dimensions", "description": "Shape, size, mass and the ranges these take across examples.", "findings": [ { "id": "measurable-dimensions", "name": "Measurable dimensions and their units", "description": "The quantities worth recording and the units they are recorded in.", "questions": [ { "id": "measurable-dimensions-q01", "text": "What identifies and describes the dimensions of a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "measurable-dimensions-q02", "text": "Who or what asserted this about the dimensions of a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "measurable-dimensions-q03", "text": "What may an agent decide or do once the dimensions of a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "material-and-composition", "name": "Material and composition", "description": "Materials, parts and how they are put together.", "findings": [ { "id": "parts-and-materials", "name": "Parts and materials", "description": "What a COVID-19 vaccine is built from and which parts are replaceable.", "questions": [ { "id": "parts-and-materials-q01", "text": "What identifies and describes the composition of a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "parts-and-materials-q02", "text": "Who or what asserted this about the composition of a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "parts-and-materials-q03", "text": "What may an agent decide or do once the composition of a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "condition-and-integrity", "name": "Condition and integrity", "description": "Wear, damage, health and the difference between working and broken.", "findings": [ { "id": "condition-assessment", "name": "Condition, damage and health", "description": "How the condition of a COVID-19 vaccine is judged and by whom.", "questions": [ { "id": "condition-assessment-q01", "text": "What identifies and describes the condition of a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "condition-assessment-q02", "text": "Who or what asserted this about the condition of a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "condition-assessment-q03", "text": "What may an agent decide or do once the condition of a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "place-and-movement", "name": "Place and movement", "description": "Where a COVID-19 vaccine is, how it got there and where it may go (varies).", "rationale": "A thing that can move needs its position recorded with a time, or every later claim about it is about a place it has left.", "layers": [ { "id": "location-and-placement", "name": "Location and placement", "description": "Position, containment and the reference frame the position is given in.", "findings": [ { "id": "position-and-frame", "name": "Position, container and reference frame", "description": "Where a COVID-19 vaccine is, and what that position is measured against.", "questions": [ { "id": "position-and-frame-q01", "text": "What identifies and describes the location of a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "position-and-frame-q02", "text": "Who or what asserted this about the location of a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "position-and-frame-q03", "text": "What may an agent decide or do once the location of a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "movement-and-transfer", "name": "Movement and transfer", "description": "How a COVID-19 vaccine is carried, installed or relocated.", "findings": [ { "id": "movement-events", "name": "Movement events and constraints", "description": "What counts as a movement, what records it and what limits it.", "questions": [ { "id": "movement-events-q01", "text": "What identifies and describes the movement of a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "movement-events-q02", "text": "Who or what asserted this about the movement of a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "movement-events-q03", "text": "What may an agent decide or do once the movement of a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a COVID-19 vaccine passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a COVID-19 vaccine between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a COVID-19 vaccine, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a COVID-19 vaccine is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "use-and-operation", "name": "Use and operation", "description": "What can be done with a COVID-19 vaccine and what it takes to do it.", "rationale": "An agent that can recognise a thing but not act on it has only half a model.", "layers": [ { "id": "intended-use", "name": "Intended use and function", "description": "What a COVID-19 vaccine is for, and what it is used for anyway.", "findings": [ { "id": "function-and-purpose", "name": "Function, purpose and misuse", "description": "The function a COVID-19 vaccine performs and the uses that fall outside it.", "questions": [ { "id": "function-and-purpose-q01", "text": "What identifies and describes the use of a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "function-and-purpose-q02", "text": "Who or what asserted this about the use of a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "function-and-purpose-q03", "text": "What may an agent decide or do once the use of a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "handling-and-procedure", "name": "Handling and procedure", "description": "The steps, skills and tools involved in using a COVID-19 vaccine.", "findings": [ { "id": "procedures-and-skills", "name": "Procedures, skills and required tools", "description": "What an agent needs before it can act on a COVID-19 vaccine at all.", "questions": [ { "id": "procedures-and-skills-q01", "text": "What identifies and describes handling a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "procedures-and-skills-q02", "text": "Who or what asserted this about handling a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "procedures-and-skills-q03", "text": "What may an agent decide or do once handling a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a COVID-19 vaccine came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a COVID-19 vaccine and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a COVID-19 vaccine is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a COVID-19 vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a COVID-19 vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a COVID-19 vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 6, "layers": 13, "findings": 15, "questions": 45 } } } }